Published online before print September 4, 2006, doi: 10.1161/CIRCULATIONAHA.106.632430
(Circulation. 2006;114:1269-1276.)
© 2006 American Heart Association, Inc.
Heart Failure |
Transcriptional Genomics Associates FOX Transcription Factors With Human Heart Failure
From the Department of Genetics and Penn Center for Bioinformatics (S.H., J.W.), Department of Biostatistics, Center for Clinical Epidemiology and Biostatistics (M.E.P.), and Penn Cardiovascular Institute (J.M.G., M.S.P., J.A.E., E.E.M., K.B.M., T.P.C.), University of Pennsylvania School of Medicine, Philadelphia.
Correspondence to Thomas P. Cappola, MD, ScM, 6 Penn Tower, 3400 Spruce St, Philadelphia, PA 19104. E-mail thomas.cappola{at}uphs.upenn.edu
Received April 9, 2006; revision received July 18, 2006; accepted July 25, 2006.
Background— Specific transcription factors (TFs) modulate cardiac gene expression in murine models of heart failure, but their relevance in human subjects remains untested. We developed and applied a computational approach called transcriptional genomics to test the hypothesis that a discrete set of cardiac TFs is associated with human heart failure.
Methods and Results— RNA isolates from failing (n=196) and nonfailing (n=16) human hearts were hybridized with Affymetrix HU133A arrays, and differentially expressed heart failure genes were determined. TF binding sites overrepresented in the –5-kb promoter sequences of these heart failure genes were then determined with the use of public genome sequence databases. Binding sites for TFs identified in murine heart failure models (MEF2, NKX, NF-AT, and GATA) were significantly overrepresented in promoters of human heart failure genes (P<0.002; false discovery rate 2% to 4%). In addition, binding sites for FOX TFs showed substantial overrepresentation in both advanced human and early murine heart failure (P<0.002 and false discovery rate <4% for each). A role for FOX TFs was supported further by expression of FOXC1, C2, P1, P4, and O1A in failing human cardiac myocytes at levels similar to established hypertrophic TFs and by abundant FOXP1 protein in failing human cardiac myocyte nuclei.
Conclusions— Our results provide the first evidence that specific TFs identified in murine models (MEF2, NKX, NFAT, and GATA) are associated with human heart failure. Moreover, these data implicate specific members of the FOX family of TFs (FOXC1, C2, P1, P4, and O1A) not previously suggested in heart failure pathogenesis. These findings provide a crucial link between animal models and human disease and suggest a specific role for FOX signaling in modulating the hypertrophic response of the heart to stress in humans.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  A. Sengupta, J. D. Molkentin, and K. E. Yutzey FoxO Transcription Factors Promote Autophagy in Cardiomyocytes J. Biol. Chem., October 9, 2009; 284(41): 28319 - 28331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Rao, Y. Toyama, H. R. Chiang, S. Gupta, M. Bauer, R. Medvid, F. Reinhardt, R. Liao, M. Krieger, R. Jaenisch, et al. Loss of Cardiac microRNA-Mediated Regulation Leads to Dilated Cardiomyopathy and Heart Failure Circ. Res., September 11, 2009; 105(6): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Putt, S. Hannenhalli, Y. Lu, P. Haines, H. R. Chandrupatla, E. E. Morrisey, K. B. Margulies, and T. P. Cappola Evidence for Coregulation of Myocardial Gene Expression by MEF2 and NFAT in Human Heart Failure Circ Cardiovasc Genet, June 1, 2009; 2(3): 212 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Margulies, D. P. Bednarik, and D. L. Dries Genomics, transcriptional profiling, and heart failure. J. Am. Coll. Cardiol., May 12, 2009; 53(19): 1752 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Fermin, A. Barac, S. Lee, S. P. Polster, S. Hannenhalli, T. L. Bergemann, S. Grindle, D. B. Dyke, F. Pagani, L. W. Miller, et al. Sex and Age Dimorphism of Myocardial Gene Expression in Nonischemic Human Heart Failure Circ Cardiovasc Genet, December 1, 2008; 1(2): 117 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Swift, B. R. Gaume, K. M. Small, B. J. Aronow, and S. B. Liggett Differential coupling of Arg- and Gly389 polymorphic forms of the {beta}1-adrenergic receptor leads to pathogenic cardiac gene regulatory programs Physiol Genomics, September 17, 2008; 35(1): 123 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Dorn II and S. J. Matkovich Put Your Chips on Transcriptomics Circulation, July 15, 2008; 118(3): 216 - 218. [Full Text] [PDF]
|
|
|
|
|
|
R. Kuner, A. S. Barth, M. Ruschhaupt, A. Buness, L. Zwermann, E. Kreuzer, G. Steinbeck, A. Poustka, H. Sultmann, and M. Nabauer Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies Physiol Genomics, June 1, 2008; 34(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Evans-Anderson, C. M. Alfieri, and K. E. Yutzey Regulation of Cardiomyocyte Proliferation and Myocardial Growth During Development by FOXO Transcription Factors Circ. Res., March 28, 2008; 102(6): 686 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Philip-Couderc, N. I. Tavares, A. Roatti, R. Lerch, C. Montessuit, and A. J. Baertschi Forkhead Transcription Factors Coordinate Expression of Myocardial KATP Channel Subunits and Energy Metabolism Circ. Res., February 1, 2008; 102(2): e20 - e35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Cappola Molecular Remodeling in Human Heart Failure J. Am. Coll. Cardiol., January 15, 2008; 51(2): 137 - 138. [Full Text] [PDF]
|
|